Give Mims A Chance

I recently received my first copy of The Scientist (the May 13, 1991, issue), in which I read the article about Forrest Mims III [page 12]. There were a lot of points raised about his raising false issues, being a religious fundamentalist, controlling the content of Scientific American, compromising his knowledge of science in favor of his religious beliefs, and not being able to communicate about science. From the same article, I gathered that Mims has a track record that speaks for itself. I

Written byLeardon Keleher
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I recently received my first copy of The Scientist (the May 13, 1991, issue), in which I read the article about Forrest Mims III [page 12]. There were a lot of points raised about his raising false issues, being a religious fundamentalist, controlling the content of Scientific American, compromising his knowledge of science in favor of his religious beliefs, and not being able to communicate about science.

From the same article, I gathered that Mims has a track record that speaks for itself. It seems to me that the issues about his unsuitability for the job should never have come up once Scientific American had proof of his writing. I'm sure Scientific American reviewed his previous work before commissioning him. If they think his writing is suddenly going to change, why not lay down some ground rules and give him a chance?

LEARDON KELEHER Scientific Editor Hayashibara Biochemical Laboratories Inc. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies